The FEARS datasets include adverse drug events for mulitpe periods. The FDA released the datasets publicly. More information can be seen in the website of FDA:https://open.fda.gov/data/faers/
A 92-year-old woman with normal systolic function had recently begun using the newly approved phosphodiesterase III inhibitor cilostazol when she was admitted with lower-extremity pain. Cilostazol is
